Svalina Matthew N, Sullivan Regina, Restrepo Diego, Huntsman Molly M
Medical Scientist Training Program, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Neuroscience Graduate Program, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Front Integr Neurosci. 2023 Mar 9;17:1128529. doi: 10.3389/fnint.2023.1128529. eCollection 2023.
Fragile X syndrome (FXS) is a neurodevelopmental disorder caused by a repeat expansion mutation in the promotor region of the gene resulting in transcriptional silencing and loss of function of fragile X messenger ribonucleoprotein 1 protein (FMRP). FMRP has a well-defined role in the early development of the brain. Thus, loss of the FMRP has well-known consequences for normal cellular and synaptic development leading to a variety of neuropsychiatric disorders including an increased prevalence of amygdala-based disorders. Despite our detailed understanding of the pathophysiology of FXS, the precise cellular and circuit-level underpinnings of amygdala-based disorders is incompletely understood. In this review, we discuss the development of the amygdala, the role of neuromodulation in the critical period plasticity, and recent advances in our understanding of how synaptic and circuit-level changes in the basolateral amygdala contribute to the behavioral manifestations seen in FXS.
脆性X综合征(FXS)是一种神经发育障碍,由该基因启动子区域的重复扩增突变引起,导致脆性X信使核糖核蛋白1(FMRP)转录沉默和功能丧失。FMRP在大脑早期发育中具有明确的作用。因此,FMRP的缺失对正常细胞和突触发育具有众所周知的影响,导致多种神经精神疾病,包括以杏仁核为基础的疾病患病率增加。尽管我们对FXS的病理生理学有详细的了解,但对以杏仁核为基础的疾病的确切细胞和回路水平基础仍不完全清楚。在这篇综述中,我们讨论了杏仁核的发育、神经调节在关键期可塑性中的作用,以及我们对基底外侧杏仁核的突触和回路水平变化如何导致FXS中所见行为表现的理解的最新进展。